Pediatrics 116(4):933–938īerlin CI, Hood LJ, Morlet T, Wilensky D, Li L, Mattingly KR et al (2010) Multi-site diagnosis and management of 260 patients with auditory Neuropathy/Dys-synchrony (auditory neuropathy spectrum Disorder*). NeuroReport 10(16):3429–3435īerg AL, Spitzer JB, Towers HM, Bartosiewicz C, Diamond BE (2005) Newborn hearing screening in the NICU: profile of failed auditory brainstem response/passed otoacoustic emission. Zeng FG, Oba S, Garde S, Sininger Y, Starr A (1999) Temporal and speech processing deficits in auditory neuropathy. Zeng FG, Kong YY, Michalewski HJ, Starr A (2005) Perceptual consequences of disrupted auditory nerve activity. Rance G, McKay C, Grayden D (2004) Perceptual characterization of children with auditory neuropathy. Rance G, Cone-Wesson B, Wunderlich J, Dowell R (2002) Speech perception and cortical event related potentials in children with auditory neuropathy. Kraus N, Bradlow AR, Cheatham MA, Cunningham J, King CD, Koch DB et al (2000) Consequences of neural asynchrony: a case of auditory neuropathy. Starr A, Picton TW, Sininger Y, Hood LJ, Berlin CI (1996) Auditory neuropathy. Sininger Y, Starr A (2001) Auditory neuropathy: a new perspective on hearing disorders. Rance G, Beer DE, Cone-Wesson B, Shepherd RK, Dowell RC, King AM et al (1999) Clinical findings for a group of infants and young children with auditory neuropathy. Hood LJ, Berlin CI, Bordelon J, Rose K (2003) Patients with auditory neuropathy/dys-synchrony lack efferent suppression of transient evoked otoacoustic emissions. Rance G, Starr A (2015) Pathophysiological mechanisms and functional hearing consequences of auditory neuropathy. Often young females are affected causing significant impairment in speech perception and disability. Hence ANSD is not a rare clinical finding in adults with sensory neural hearing loss, but its prevalence was estimated to be lower in Indian population. The clinical characteristics of ANSD shows impairment in speech perception irrespective of degree of hearing loss, preserved cochlear functions and abnormal ABR. The prevalence of ANSD in adult population with sensory neural hearing loss in our study is 1.32% per 1000 adults. Out of 1343 adults with sensory neural hearing loss, 24 (1.78%) adults were diagnosed as ANSD.
Out of 8682 patients, 1343 (15.46%) of them had sensory neural hearing loss of varying degrees. A total of 8682 adult population was evaluated during the period of 2017 to 2018. Patients with indications of ANSD in case history and routine audiological evaluation were further evaluated using distortion product otoacoustic emissions and ABR. All patients reported to the department with auditory and vestibular symptoms underwent case history, otoscopic examination, and routine audiological evaluation (pure tone audiometry, speech audiometry and immittance audiometry). A prospective study was conducted on the adult population ( ≥ 18 years) attending ENT outpatients clinic at Rajiv Gandhi Government General Hospital, Chennai. The aim of the study is to estimate the prevalence and evaluate the audiological characteristics of ANSD in adult population with sensory neural hearing loss. Discussion: Screening older adults with sensory impairments for depression and anxiety, and screening those with late-life depression and anxiety for sensory impairments, may identify treatment opportunities to optimize health and well-being.Īging epidemiology hearing impairment sensory impairment vision impairment.Auditory neuropathy spectrum disorder (ANSD) is a heterogenous group of disorder characterized by abnormalities in auditory brainstem responses (ABR) with preserved otoacoustic emissions and/or cochlear microphonics. Auditory, vision, and dual impairment were also associated with an increased risk for depressive and anxiety symptoms that persist or were of new onset after 1 year. Results: Auditory, vision, and dual impairment were associated with an increased risk of depressive and anxiety symptoms in multivariable analyses accounting for sociodemographics, medical comorbidity, and functional impairment. Auditory and vision impairment were determined by self-report, and depressive and anxiety symptoms were evaluated by the two-item Patient Health Questionnaire (PHQ-2) and two-item Generalized Anxiety Disorder Scale (GAD-2), respectively. Method: Our study included 7,507 older adults from the National Health & Aging Trends Study, a nationally representative sample of U.S.
Objective: The objective of the study is to examine the association of auditory, vision, and dual sensory impairment with late-life depressive and anxiety symptoms.
0 kommentar(er)
